On Tuesday, Dyne Therapeutics Inc (NASDAQ: DYN) was -0.56% drop from the session before settling in for the closing price of $28.78. A 52-week range for DYN has been $7.93 – $47.45.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 23.94%. With a float of $75.28 million, this company’s outstanding shares have now reached $100.40 million.
The firm has a total of 141 workers. Let’s measure their productivity. In terms of profitability, gross margin is 48.52%, operating margin of -7156.28%, and the pretax margin is -6800.4%.
Dyne Therapeutics Inc (DYN) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Dyne Therapeutics Inc stocks. The insider ownership of Dyne Therapeutics Inc is 25.02%, while institutional ownership is 86.55%. The most recent insider transaction that took place on Oct 18 ’24, was worth 471,636. In this transaction Director of this company sold 13,414 shares at a rate of $35.16, taking the stock ownership to the 73,225 shares. Before that another transaction happened on Oct 21 ’24, when Company’s Director sold 121 for $35.06, making the entire transaction worth $4,242. This insider now owns 73,104 shares in total.
Dyne Therapeutics Inc (DYN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 23.94% per share during the next fiscal year.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
You can see what Dyne Therapeutics Inc (DYN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 26.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.58, a number that is poised to hit -0.71 in the next quarter and is forecasted to reach -3.17 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
Analysing the last 5-days average volume posted by the [Dyne Therapeutics Inc, DYN], we can find that recorded value of 0.93 million was lower than the volume posted last year of 1.5 million. As of the previous 9 days, the stock’s Stochastic %D was 19.45%. Additionally, its Average True Range was 1.43.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 21.23%, which indicates a significant increase from 11.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 26.41% in the past 14 days, which was lower than the 76.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.98, while its 200-day Moving Average is $31.81. Now, the first resistance to watch is $29.00. This is followed by the second major resistance level at $29.37. The third major resistance level sits at $29.75. If the price goes on to break the first support level at $28.25, it is likely to go to the next support level at $27.87. Now, if the price goes above the second support level, the third support stands at $27.50.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
There are 100,401K outstanding shares of the company, which has a market capitalization of 2.87 billion. As of now, sales total 0 K while income totals -235,940 K. Its latest quarter income was 0 K while its last quarter net income were -65,100 K.
